CD274 and Miyoshi myopathy: Since lenalidomide and pomalidomide (IMiDs) represent an efficient clinical approach in MM treatment to improve patients’ survival, studies on the regulation of PD-1/PD-L1 pathway by IMiDs have been reported [93,94].